Magenta Therapeutics

Biotechnology ResearchMassachusetts, United States2-10 Employees

Magenta Therapeutics is a small clinical-stage biotechnology company based in Cambridge, Massachusetts, focused on expanding the curative potential of stem cell transplantation for blood cancers, genetic diseases, and autoimmune diseases. It aims to develop medicines that improve the bone marrow transplant process, making it more effective, safer, and accessible to more patients. The company combines expertise in stem cell biology and biotherapeutics development with clinical and regulatory know-how and broad networks in the stem cell transplant community to advance immune reset. 

In 2023, Magenta merged with Dianthus Therapeutics, a strategic development that broadened its platform. In 2026, the company announced leadership changes with the departure of the Chief Commercial and Strategy Officer.

Sign up for free to view info

Email Format Employee directory